Journey Medical Corporation (DERM)
NASDAQ: DERM · IEX Real-Time Price · USD
3.430
-0.070 (-2.00%)
At close: Apr 26, 2024, 3:59 PM
3.400
-0.030 (-0.87%)
After-hours: Apr 26, 2024, 4:00 PM EDT
Journey Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Journey Medical stock have an average target of 7.25, with a low estimate of 6.00 and a high estimate of 8.50. The average target predicts an increase of 111.37% from the current stock price of 3.43.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 16, 2024.
Analyst Ratings
The average analyst rating for DERM stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +147.81% | Feb 16, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +74.93% | Sep 7, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $3 → $6 | Strong Buy | Maintains | $3 → $6 | +74.93% | Jul 12, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $6 → $3 | Strong Buy | Maintains | $6 → $3 | -12.54% | May 23, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +74.93% | Mar 30, 2023 |
Financial Forecast
Revenue This Year
59.17M
from 79.18M
Decreased by -25.27%
Revenue Next Year
83.68M
from 59.17M
Increased by 41.42%
EPS This Year
-0.75
from -0.21
EPS Next Year
-0.20
from -0.75
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 60.9M | 105.1M | 83.7M |
| Avg | 59.2M | 83.7M | 81.4M |
| Low | 56.8M | 62.7M | 78.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -23.0% | 77.5% | 0.1% |
| Avg | -25.3% | 41.4% | -2.8% |
| Low | -28.2% | 6.0% | -6.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.68 | 0.21 | -0.43 |
| Avg | -0.75 | -0.20 | -0.42 |
| Low | -0.81 | -0.59 | -0.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.